Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Ashwagandha (KSM-66) | Bacopa Monnieri | |
|---|---|---|
| Category | Adaptogens | Nootropics |
| Standard Dose | 600mg KSM-66 daily (300mg 2x/day) | 300-450 mg/day of standardized extract (24-55% bacosides, typically Bacognize or Synapsa brands) |
| Timing | Morning and evening with meals. Evening dose supports sleep quality via cortisol reduction. | With a fat-containing meal to improve absorption of fat-soluble bacosides. Morning or evening — some users report mild sedation. Minimum 8-12 weeks for full cognitive effects. |
| Cycle Duration | Cycle 8-12 weeks on, 2-4 weeks off (to prevent adaptogenic tolerance) | Ongoing; benefits accumulate over months. No strict cycling required. |
| Evidence Level | strong_human | strong_human |
Ashwagandha's primary bioactives are withanolides (particularly withaferin A and withanolide D). KSM-66 is a full-spectrum root extract standardized to >5% withanolides. It modulates the HPA axis by reducing cortisol output (20-30% reduction in trials), likely through GABAergic activity (withanolides are GABA-mimetic at GABA-A receptors) and by normalizing cortisol receptor (GR) sensitivity. It also inhibits the NMDA-induced neurotoxicity pathway, enhances DHEA-S production, promotes thyroid function (increases T4 to T3 conversion), upregulates antioxidant enzymes (SOD, catalase, glutathione peroxidase), and has demonstrated sirtuin-activating properties.
600mg KSM-66 daily (300mg 2x/day)
Morning and evening with meals. Evening dose supports sleep quality via cortisol reduction.
Cycle 8-12 weeks on, 2-4 weeks off (to prevent adaptogenic tolerance)
Active triterpenoid saponins (bacosides A and B) provide multifaceted neuroprotection: inhibition of acetylcholinesterase (AChE) and activation of choline acetyltransferase (ChAT) to enhance cholinergic neurotransmission; upregulation of tryptophan hydroxylase and serotonin transporter expression to modulate serotonergic tone; antioxidant neuroprotection via induction of superoxide dismutase and glutathione peroxidase; and reduction of beta-amyloid aggregation. Additionally enhances GABA signaling through GABA-A receptor subunit upregulation and glutamate decarboxylase activation.
300-450 mg/day of standardized extract (24-55% bacosides, typically Bacognize or Synapsa brands)
With a fat-containing meal to improve absorption of fat-soluble bacosides. Morning or evening — some users report mild sedation. Minimum 8-12 weeks for full cognitive effects.
Ongoing; benefits accumulate over months. No strict cycling required.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →